Tivdak 40 mg lyophilized powder for injection Images
Generic Name: tisotumab vedotin
This medication has been identified as Tivdak 40 mg lyophilized powder for injection. It is supplied by Seagen Inc.
Tivdak is used in the treatment of Cervical Cancer and belongs to the drug class miscellaneous antineoplastics. Tivdak 40 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tivdak
- Generic Name
- tisotumab vedotin
- Strength
- 40 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Seagen Inc.
- National Drug Code (NDC)
- 51144-0003
More about Tivdak (tisotumab vedotin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
